 | • レポートコード：GIR-2104Z07185 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、院内感染性尿路感染症のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。院内感染性尿路感染症の種類別市場規模（微生物検査機器、試薬・消耗品、感染予防・監視ソフトウェア）、用途別市場規模（疾病検査、薬剤耐性検査）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・院内感染性尿路感染症の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Advanced Sterilization Products、Becton、Dickinson and Company、Steris Corporation、Getinge Group、Kimberly-Clark Corporation、Cantel Medical、Biomerieux、Belimed、3M Company、Sterigenics International、Synergy Health ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：微生物検査機器、試薬・消耗品、感染予防・監視ソフトウェア ・用途別分析2016年-2026年：疾病検査、薬剤耐性検査 ・院内感染性尿路感染症の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・院内感染性尿路感染症のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・院内感染性尿路感染症のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・院内感染性尿路感染症の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・院内感染性尿路感染症の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Hospital Acquired Urinary Tract Infection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Hospital Acquired Urinary Tract Infection size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Hospital Acquired Urinary Tract Infection market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Hospital Acquired Urinary Tract Infection market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Microbial Testing Instruments
Reagents and Consumables
Infection Prevention and Surveillance Software
Market segment by Application, can be divided into
Disease Testing
Drug-resistance Testing
Market segment by players, this report covers
Advanced Sterilization Products
Becton
Dickinson and Company
Steris Corporation
Getinge Group
Kimberly-Clark Corporation
Cantel Medical
Biomerieux
Belimed
3M Company
Sterigenics International
Synergy Health
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Hospital Acquired Urinary Tract Infection
1.2 Classification of Hospital Acquired Urinary Tract Infection by Type
1.2.1 Overview: Global Hospital Acquired Urinary Tract Infection Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Hospital Acquired Urinary Tract Infection Revenue Market Share by Type in 2020
1.2.3 Microbial Testing Instruments
1.2.4 Reagents and Consumables
1.2.5 Infection Prevention and Surveillance Software
1.3 Global Hospital Acquired Urinary Tract Infection Market by Application
1.3.1 Overview: Global Hospital Acquired Urinary Tract Infection Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Disease Testing
1.3.3 Drug-resistance Testing
1.4 Global Hospital Acquired Urinary Tract Infection Market Size & Forecast
1.5 Global Hospital Acquired Urinary Tract Infection Market Size and Forecast by Region
1.5.1 Global Hospital Acquired Urinary Tract Infection Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Hospital Acquired Urinary Tract Infection Market Size by Region, (2016-2021)
1.5.3 North America Hospital Acquired Urinary Tract Infection Market Size and Prospect (2016-2026)
1.5.4 Europe Hospital Acquired Urinary Tract Infection Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Hospital Acquired Urinary Tract Infection Market Size and Prospect (2016-2026)
1.5.6 South America Hospital Acquired Urinary Tract Infection Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Hospital Acquired Urinary Tract Infection Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Hospital Acquired Urinary Tract Infection Market Drivers
1.6.2 Hospital Acquired Urinary Tract Infection Market Restraints
1.6.3 Hospital Acquired Urinary Tract Infection Trends Analysis
2 Company Profiles
2.1 Advanced Sterilization Products
2.1.1 Advanced Sterilization Products Details
2.1.2 Advanced Sterilization Products Major Business
2.1.3 Advanced Sterilization Products Hospital Acquired Urinary Tract Infection Product and Solutions
2.1.4 Advanced Sterilization Products Hospital Acquired Urinary Tract Infection Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Advanced Sterilization Products Recent Developments and Future Plans
2.2 Becton
2.2.1 Becton Details
2.2.2 Becton Major Business
2.2.3 Becton Hospital Acquired Urinary Tract Infection Product and Solutions
2.2.4 Becton Hospital Acquired Urinary Tract Infection Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Becton Recent Developments and Future Plans
2.3 Dickinson and Company
2.3.1 Dickinson and Company Details
2.3.2 Dickinson and Company Major Business
2.3.3 Dickinson and Company Hospital Acquired Urinary Tract Infection Product and Solutions
2.3.4 Dickinson and Company Hospital Acquired Urinary Tract Infection Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Dickinson and Company Recent Developments and Future Plans
2.4 Steris Corporation
2.4.1 Steris Corporation Details
2.4.2 Steris Corporation Major Business
2.4.3 Steris Corporation Hospital Acquired Urinary Tract Infection Product and Solutions
2.4.4 Steris Corporation Hospital Acquired Urinary Tract Infection Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Steris Corporation Recent Developments and Future Plans
2.5 Getinge Group
2.5.1 Getinge Group Details
2.5.2 Getinge Group Major Business
2.5.3 Getinge Group Hospital Acquired Urinary Tract Infection Product and Solutions
2.5.4 Getinge Group Hospital Acquired Urinary Tract Infection Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Getinge Group Recent Developments and Future Plans
2.6 Kimberly-Clark Corporation
2.6.1 Kimberly-Clark Corporation Details
2.6.2 Kimberly-Clark Corporation Major Business
2.6.3 Kimberly-Clark Corporation Hospital Acquired Urinary Tract Infection Product and Solutions
2.6.4 Kimberly-Clark Corporation Hospital Acquired Urinary Tract Infection Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Kimberly-Clark Corporation Recent Developments and Future Plans
2.7 Cantel Medical
2.7.1 Cantel Medical Details
2.7.2 Cantel Medical Major Business
2.7.3 Cantel Medical Hospital Acquired Urinary Tract Infection Product and Solutions
2.7.4 Cantel Medical Hospital Acquired Urinary Tract Infection Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Cantel Medical Recent Developments and Future Plans
2.8 Biomerieux
2.8.1 Biomerieux Details
2.8.2 Biomerieux Major Business
2.8.3 Biomerieux Hospital Acquired Urinary Tract Infection Product and Solutions
2.8.4 Biomerieux Hospital Acquired Urinary Tract Infection Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Biomerieux Recent Developments and Future Plans
2.9 Belimed
2.9.1 Belimed Details
2.9.2 Belimed Major Business
2.9.3 Belimed Hospital Acquired Urinary Tract Infection Product and Solutions
2.9.4 Belimed Hospital Acquired Urinary Tract Infection Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Belimed Recent Developments and Future Plans
2.10 3M Company
2.10.1 3M Company Details
2.10.2 3M Company Major Business
2.10.3 3M Company Hospital Acquired Urinary Tract Infection Product and Solutions
2.10.4 3M Company Hospital Acquired Urinary Tract Infection Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 3M Company Recent Developments and Future Plans
2.11 Sterigenics International
2.11.1 Sterigenics International Details
2.11.2 Sterigenics International Major Business
2.11.3 Sterigenics International Hospital Acquired Urinary Tract Infection Product and Solutions
2.11.4 Sterigenics International Hospital Acquired Urinary Tract Infection Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Sterigenics International Recent Developments and Future Plans
2.12 Synergy Health
2.12.1 Synergy Health Details
2.12.2 Synergy Health Major Business
2.12.3 Synergy Health Hospital Acquired Urinary Tract Infection Product and Solutions
2.12.4 Synergy Health Hospital Acquired Urinary Tract Infection Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Synergy Health Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Hospital Acquired Urinary Tract Infection Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Hospital Acquired Urinary Tract Infection Players Market Share
3.2.2 Top 10 Hospital Acquired Urinary Tract Infection Players Market Share
3.2.3 Market Competition Trend
3.3 Hospital Acquired Urinary Tract Infection Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Hospital Acquired Urinary Tract Infection Revenue and Market Share by Type (2016-2021)
4.2 Global Hospital Acquired Urinary Tract Infection Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Hospital Acquired Urinary Tract Infection Revenue Market Share by Application (2016-2021)
5.2 Hospital Acquired Urinary Tract Infection Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Hospital Acquired Urinary Tract Infection Revenue by Type (2016-2026)
6.2 North America Hospital Acquired Urinary Tract Infection Revenue by Application (2016-2026)
6.3 North America Hospital Acquired Urinary Tract Infection Market Size by Country
6.3.1 North America Hospital Acquired Urinary Tract Infection Revenue by Country (2016-2026)
6.3.2 United States Hospital Acquired Urinary Tract Infection Market Size and Forecast (2016-2026)
6.3.3 Canada Hospital Acquired Urinary Tract Infection Market Size and Forecast (2016-2026)
6.3.4 Mexico Hospital Acquired Urinary Tract Infection Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Hospital Acquired Urinary Tract Infection Revenue by Type (2016-2026)
7.2 Europe Hospital Acquired Urinary Tract Infection Revenue by Application (2016-2026)
7.3 Europe Hospital Acquired Urinary Tract Infection Market Size by Country
7.3.1 Europe Hospital Acquired Urinary Tract Infection Revenue by Country (2016-2026)
7.3.2 Germany Hospital Acquired Urinary Tract Infection Market Size and Forecast (2016-2026)
7.3.3 France Hospital Acquired Urinary Tract Infection Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Hospital Acquired Urinary Tract Infection Market Size and Forecast (2016-2026)
7.3.5 Russia Hospital Acquired Urinary Tract Infection Market Size and Forecast (2016-2026)
7.3.6 Italy Hospital Acquired Urinary Tract Infection Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Hospital Acquired Urinary Tract Infection Revenue by Type (2016-2026)
8.2 Asia-Pacific Hospital Acquired Urinary Tract Infection Revenue by Application (2016-2026)
8.3 Asia-Pacific Hospital Acquired Urinary Tract Infection Market Size by Region
8.3.1 Asia-Pacific Hospital Acquired Urinary Tract Infection Revenue by Region (2016-2026)
8.3.2 China Hospital Acquired Urinary Tract Infection Market Size and Forecast (2016-2026)
8.3.3 Japan Hospital Acquired Urinary Tract Infection Market Size and Forecast (2016-2026)
8.3.4 South Korea Hospital Acquired Urinary Tract Infection Market Size and Forecast (2016-2026)
8.3.5 India Hospital Acquired Urinary Tract Infection Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Hospital Acquired Urinary Tract Infection Market Size and Forecast (2016-2026)
8.3.7 Australia Hospital Acquired Urinary Tract Infection Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Hospital Acquired Urinary Tract Infection Revenue by Type (2016-2026)
9.2 South America Hospital Acquired Urinary Tract Infection Revenue by Application (2016-2026)
9.3 South America Hospital Acquired Urinary Tract Infection Market Size by Country
9.3.1 South America Hospital Acquired Urinary Tract Infection Revenue by Country (2016-2026)
9.3.2 Brazil Hospital Acquired Urinary Tract Infection Market Size and Forecast (2016-2026)
9.3.3 Argentina Hospital Acquired Urinary Tract Infection Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Hospital Acquired Urinary Tract Infection Revenue by Type (2016-2026)
10.2 Middle East & Africa Hospital Acquired Urinary Tract Infection Revenue by Application (2016-2026)
10.3 Middle East & Africa Hospital Acquired Urinary Tract Infection Market Size by Country
10.3.1 Middle East & Africa Hospital Acquired Urinary Tract Infection Revenue by Country (2016-2026)
10.3.2 Turkey Hospital Acquired Urinary Tract Infection Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Hospital Acquired Urinary Tract Infection Market Size and Forecast (2016-2026)
10.3.4 UAE Hospital Acquired Urinary Tract Infection Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Hospital Acquired Urinary Tract Infection Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Hospital Acquired Urinary Tract Infection Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Hospital Acquired Urinary Tract Infection Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Hospital Acquired Urinary Tract Infection Revenue (USD Million) by Region (2016-2021)
Table 5. Global Hospital Acquired Urinary Tract Infection Revenue Market Share by Region (2021-2026)
Table 6. Advanced Sterilization Products Corporate Information, Head Office, and Major Competitors
Table 7. Advanced Sterilization Products Major Business
Table 8. Advanced Sterilization Products Hospital Acquired Urinary Tract Infection Product and Solutions
Table 9. Advanced Sterilization Products Hospital Acquired Urinary Tract Infection Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Becton Corporate Information, Head Office, and Major Competitors
Table 11. Becton Major Business
Table 12. Becton Hospital Acquired Urinary Tract Infection Product and Solutions
Table 13. Becton Hospital Acquired Urinary Tract Infection Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Dickinson and Company Corporate Information, Head Office, and Major Competitors
Table 15. Dickinson and Company Major Business
Table 16. Dickinson and Company Hospital Acquired Urinary Tract Infection Product and Solutions
Table 17. Dickinson and Company Hospital Acquired Urinary Tract Infection Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Steris Corporation Corporate Information, Head Office, and Major Competitors
Table 19. Steris Corporation Major Business
Table 20. Steris Corporation Hospital Acquired Urinary Tract Infection Product and Solutions
Table 21. Steris Corporation Hospital Acquired Urinary Tract Infection Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Getinge Group Corporate Information, Head Office, and Major Competitors
Table 23. Getinge Group Major Business
Table 24. Getinge Group Hospital Acquired Urinary Tract Infection Product and Solutions
Table 25. Getinge Group Hospital Acquired Urinary Tract Infection Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Kimberly-Clark Corporation Corporate Information, Head Office, and Major Competitors
Table 27. Kimberly-Clark Corporation Major Business
Table 28. Kimberly-Clark Corporation Hospital Acquired Urinary Tract Infection Product and Solutions
Table 29. Kimberly-Clark Corporation Hospital Acquired Urinary Tract Infection Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Cantel Medical Corporate Information, Head Office, and Major Competitors
Table 31. Cantel Medical Major Business
Table 32. Cantel Medical Hospital Acquired Urinary Tract Infection Product and Solutions
Table 33. Cantel Medical Hospital Acquired Urinary Tract Infection Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Biomerieux Corporate Information, Head Office, and Major Competitors
Table 35. Biomerieux Major Business
Table 36. Biomerieux Hospital Acquired Urinary Tract Infection Product and Solutions
Table 37. Biomerieux Hospital Acquired Urinary Tract Infection Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Belimed Corporate Information, Head Office, and Major Competitors
Table 39. Belimed Major Business
Table 40. Belimed Hospital Acquired Urinary Tract Infection Product and Solutions
Table 41. Belimed Hospital Acquired Urinary Tract Infection Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. 3M Company Corporate Information, Head Office, and Major Competitors
Table 43. 3M Company Major Business
Table 44. 3M Company Hospital Acquired Urinary Tract Infection Product and Solutions
Table 45. 3M Company Hospital Acquired Urinary Tract Infection Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Sterigenics International Corporate Information, Head Office, and Major Competitors
Table 47. Sterigenics International Major Business
Table 48. Sterigenics International Hospital Acquired Urinary Tract Infection Product and Solutions
Table 49. Sterigenics International Hospital Acquired Urinary Tract Infection Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Synergy Health Corporate Information, Head Office, and Major Competitors
Table 51. Synergy Health Major Business
Table 52. Synergy Health Hospital Acquired Urinary Tract Infection Product and Solutions
Table 53. Synergy Health Hospital Acquired Urinary Tract Infection Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Global Hospital Acquired Urinary Tract Infection Revenue (USD Million) by Players (2019-2021)
Table 55. Global Hospital Acquired Urinary Tract Infection Revenue Share by Players (2019-2021)
Table 56. Breakdown of Hospital Acquired Urinary Tract Infection by Company Type (Tier 1, Tier 2 and Tier 3)
Table 57. Hospital Acquired Urinary Tract Infection Players Head Office, Products and Services Provided
Table 58. Hospital Acquired Urinary Tract Infection Mergers & Acquisitions in the Past Five Years
Table 59. Hospital Acquired Urinary Tract Infection New Entrants and Expansion Plans
Table 60. Global Hospital Acquired Urinary Tract Infection Revenue (USD Million) by Type (2016-2021)
Table 61. Global Hospital Acquired Urinary Tract Infection Revenue Share by Type (2016-2021)
Table 62. Global Hospital Acquired Urinary Tract Infection Revenue Forecast by Type (2021-2026)
Table 63. Global Hospital Acquired Urinary Tract Infection Revenue by Application (2016-2021)
Table 64. Global Hospital Acquired Urinary Tract Infection Revenue Forecast by Application (2021-2026)
Table 65. North America Hospital Acquired Urinary Tract Infection Revenue by Type (2016-2021) & (USD Million)
Table 66. North America Hospital Acquired Urinary Tract Infection Revenue by Type (2021-2026) & (USD Million)
Table 67. North America Hospital Acquired Urinary Tract Infection Revenue by Application (2016-2021) & (USD Million)
Table 68. North America Hospital Acquired Urinary Tract Infection Revenue by Application (2021-2026) & (USD Million)
Table 69. North America Hospital Acquired Urinary Tract Infection Revenue by Country (2016-2021) & (USD Million)
Table 70. North America Hospital Acquired Urinary Tract Infection Revenue by Country (2021-2026) & (USD Million)
Table 71. Europe Hospital Acquired Urinary Tract Infection Revenue by Type (2016-2021) & (USD Million)
Table 72. Europe Hospital Acquired Urinary Tract Infection Revenue by Type (2021-2026) & (USD Million)
Table 73. Europe Hospital Acquired Urinary Tract Infection Revenue by Application (2016-2021) & (USD Million)
Table 74. Europe Hospital Acquired Urinary Tract Infection Revenue by Application (2021-2026) & (USD Million)
Table 75. Europe Hospital Acquired Urinary Tract Infection Revenue by Country (2016-2021) & (USD Million)
Table 76. Europe Hospital Acquired Urinary Tract Infection Revenue by Country (2021-2026) & (USD Million)
Table 77. Asia-Pacific Hospital Acquired Urinary Tract Infection Revenue by Type (2016-2021) & (USD Million)
Table 78. Asia-Pacific Hospital Acquired Urinary Tract Infection Revenue by Type (2021-2026) & (USD Million)
Table 79. Asia-Pacific Hospital Acquired Urinary Tract Infection Revenue by Application (2016-2021) & (USD Million)
Table 80. Asia-Pacific Hospital Acquired Urinary Tract Infection Revenue by Application (2021-2026) & (USD Million)
Table 81. Asia-Pacific Hospital Acquired Urinary Tract Infection Revenue by Region (2016-2021) & (USD Million)
Table 82. Asia-Pacific Hospital Acquired Urinary Tract Infection Revenue by Region (2021-2026) & (USD Million)
Table 83. South America Hospital Acquired Urinary Tract Infection Revenue by Type (2016-2021) & (USD Million)
Table 84. South America Hospital Acquired Urinary Tract Infection Revenue by Type (2021-2026) & (USD Million)
Table 85. South America Hospital Acquired Urinary Tract Infection Revenue by Application (2016-2021) & (USD Million)
Table 86. South America Hospital Acquired Urinary Tract Infection Revenue by Application (2021-2026) & (USD Million)
Table 87. South America Hospital Acquired Urinary Tract Infection Revenue by Country (2016-2021) & (USD Million)
Table 88. South America Hospital Acquired Urinary Tract Infection Revenue by Country (2021-2026) & (USD Million)
Table 89. Middle East & Africa Hospital Acquired Urinary Tract Infection Revenue by Type (2016-2021) & (USD Million)
Table 90. Middle East & Africa Hospital Acquired Urinary Tract Infection Revenue by Type (2021-2026) & (USD Million)
Table 91. Middle East & Africa Hospital Acquired Urinary Tract Infection Revenue by Application (2016-2021) & (USD Million)
Table 92. Middle East & Africa Hospital Acquired Urinary Tract Infection Revenue by Application (2021-2026) & (USD Million)
Table 93. Middle East & Africa Hospital Acquired Urinary Tract Infection Revenue by Country (2016-2021) & (USD Million)
Table 94. Middle East & Africa Hospital Acquired Urinary Tract Infection Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Hospital Acquired Urinary Tract Infection Picture
Figure 2. Global Hospital Acquired Urinary Tract Infection Revenue Market Share by Type in 2020
Figure 3. Microbial Testing Instruments
Figure 4. Reagents and Consumables
Figure 5. Infection Prevention and Surveillance Software
Figure 6. Hospital Acquired Urinary Tract Infection Revenue Market Share by Application in 2020
Figure 7. Disease Testing Picture
Figure 8. Drug-resistance Testing Picture
Figure 9. Global Hospital Acquired Urinary Tract Infection Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global Hospital Acquired Urinary Tract Infection Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global Hospital Acquired Urinary Tract Infection Revenue Market Share by Region (2016-2026)
Figure 12. Global Hospital Acquired Urinary Tract Infection Revenue Market Share by Region in 2020
Figure 13. North America Hospital Acquired Urinary Tract Infection Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe Hospital Acquired Urinary Tract Infection Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific Hospital Acquired Urinary Tract Infection Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America Hospital Acquired Urinary Tract Infection Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Hospital Acquired Urinary Tract Infection Market Drivers
Figure 18. Hospital Acquired Urinary Tract Infection Market Restraints
Figure 19. Hospital Acquired Urinary Tract Infection Market Trends
Figure 20. Advanced Sterilization Products Recent Developments and Future Plans
Figure 21. Becton Recent Developments and Future Plans
Figure 22. Dickinson and Company Recent Developments and Future Plans
Figure 23. Steris Corporation Recent Developments and Future Plans
Figure 24. Getinge Group Recent Developments and Future Plans
Figure 25. Kimberly-Clark Corporation Recent Developments and Future Plans
Figure 26. Cantel Medical Recent Developments and Future Plans
Figure 27. Biomerieux Recent Developments and Future Plans
Figure 28. Belimed Recent Developments and Future Plans
Figure 29. 3M Company Recent Developments and Future Plans
Figure 30. Sterigenics International Recent Developments and Future Plans
Figure 31. Synergy Health Recent Developments and Future Plans
Figure 33. Global Hospital Acquired Urinary Tract Infection Revenue Share by Players in 2020
Figure 34. Hospital Acquired Urinary Tract Infection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 35. Global Top 3 Players Hospital Acquired Urinary Tract Infection Revenue Market Share in 2020
Figure 36. Global Top 10 Players Hospital Acquired Urinary Tract Infection Revenue Market Share in 2020
Figure 37. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 38. Global Hospital Acquired Urinary Tract Infection Revenue Share by Type in 2020
Figure 39. Global Hospital Acquired Urinary Tract Infection Market Share Forecast by Type (2021-2026)
Figure 40. Global Hospital Acquired Urinary Tract Infection Revenue Share by Application in 2020
Figure 41. Global Hospital Acquired Urinary Tract Infection Market Share Forecast by Application (2021-2026)
Figure 42. North America Hospital Acquired Urinary Tract Infection Sales Market Share by Type (2016-2026)
Figure 43. North America Hospital Acquired Urinary Tract Infection Sales Market Share by Application (2016-2026)
Figure 44. North America Hospital Acquired Urinary Tract Infection Revenue Market Share by Country (2016-2026)
Figure 45. United States Hospital Acquired Urinary Tract Infection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Canada Hospital Acquired Urinary Tract Infection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Mexico Hospital Acquired Urinary Tract Infection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Europe Hospital Acquired Urinary Tract Infection Sales Market Share by Type (2016-2026)
Figure 49. Europe Hospital Acquired Urinary Tract Infection Sales Market Share by Application (2016-2026)
Figure 50. Europe Hospital Acquired Urinary Tract Infection Revenue Market Share by Country (2016-2026)
Figure 51. Germany Hospital Acquired Urinary Tract Infection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. France Hospital Acquired Urinary Tract Infection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. United Kingdom Hospital Acquired Urinary Tract Infection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Russia Hospital Acquired Urinary Tract Infection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Italy Hospital Acquired Urinary Tract Infection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Asia-Pacific Hospital Acquired Urinary Tract Infection Sales Market Share by Type (2016-2026)
Figure 57. Asia-Pacific Hospital Acquired Urinary Tract Infection Sales Market Share by Application (2016-2026)
Figure 58. Asia-Pacific Hospital Acquired Urinary Tract Infection Revenue Market Share by Region (2016-2026)
Figure 59. China Hospital Acquired Urinary Tract Infection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan Hospital Acquired Urinary Tract Infection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South Korea Hospital Acquired Urinary Tract Infection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India Hospital Acquired Urinary Tract Infection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia Hospital Acquired Urinary Tract Infection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia Hospital Acquired Urinary Tract Infection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America Hospital Acquired Urinary Tract Infection Sales Market Share by Type (2016-2026)
Figure 66. South America Hospital Acquired Urinary Tract Infection Sales Market Share by Application (2016-2026)
Figure 67. South America Hospital Acquired Urinary Tract Infection Revenue Market Share by Country (2016-2026)
Figure 68. Brazil Hospital Acquired Urinary Tract Infection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Argentina Hospital Acquired Urinary Tract Infection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Middle East and Africa Hospital Acquired Urinary Tract Infection Sales Market Share by Type (2016-2026)
Figure 71. Middle East and Africa Hospital Acquired Urinary Tract Infection Sales Market Share by Application (2016-2026)
Figure 72. Middle East and Africa Hospital Acquired Urinary Tract Infection Revenue Market Share by Country (2016-2026)
Figure 73. Turkey Hospital Acquired Urinary Tract Infection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia Hospital Acquired Urinary Tract Infection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. UAE Hospital Acquired Urinary Tract Infection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Methodology
Figure 77. Research Process and Data Source
世界の院内感染性尿路感染症検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Hospital-acquired Urinary Tract Infection Testing Market The global Hospital-acquired Urinary Tract Infection Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard …- 世界の院内感染性尿路感染症市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Hospital Acquired Urinary Tract Infection Market The global Hospital Acquired Urinary Tract Infection market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in anal…
- 世界の院内感染性尿路感染症市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Hospital Acquired Urinary Tract Infection Market The global Hospital Acquired Urinary Tract Infection market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in anal…
- 世界の尿路感染症治療市場規模・現状・予測（2021年-2027年） Urinary tract infection (UTI) is a common infections of the urinary tract, which consists of the kidneys, ureters, bladder, urethra or prostate gland. This trend of increment in the prevalence rate of diabetes among adults is expected to continue during the forecast period. Therefore, with increasin…
- 世界の尿路感染症治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Urinary Tract Infection Therapeutics Market The global Urinary Tract Infection Therapeutics market size is projected to reach US$ 81750 million by 2026, from US$ 71130 million in 2019, at a CAGR of 2.0% during 2021-2026. With industry-standard accuracy in analysi…